---
title: "Biotronik’s Freesolve resorbable magnesium scaffold gains CE mark"
date: "2024-02-13T09:57:00.000Z"
publishedDate: "13 février 2024"
summary: "Biotronik has announced the CE approval and launch of the Freesolve resorbable magnesium scaffold (RMS). This third generation RMS has been engineered to provide optimised vessel support, yet achieves magnesium resorption within 12 months, the company says in a press release."
importance: ""
sourceUrl: "https://cardiovascularnews.com/biotroniks-freesolve-resorbable-magnesium-scaffold-gains-ce-mark/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2024-02-13-biotroniks-freesolve-resorbable-magnesium-scaffold-gains-ce-mark"
imageUrl: "https://cardiovascularnews.com/wp-content/uploads/sites/14/2024/02/Freesolve.png"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/biotroniks-freesolve-resorbable-magnesium-scaffold-gains-ce-mark/"
---

![Biotronik’s Freesolve resorbable magnesium scaffold gains CE mark](https://cardiovascularnews.com/wp-content/uploads/sites/14/2024/02/Freesolve.png)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/biotroniks-freesolve-resorbable-magnesium-scaffold-gains-ce-mark/*

## L’essentiel

Biotronik has announced the CE approval and launch of the Freesolve resorbable magnesium scaffold (RMS). This third generation RMS has been engineered to provide optimised vessel support, yet achieves magnesium resorption within 12 months, the company says in a press release.

## Lien source

https://cardiovascularnews.com/biotroniks-freesolve-resorbable-magnesium-scaffold-gains-ce-mark/
